The metabolic syndrome in critically ill patients

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 5, 2011, Pages 835-845

  Robinson, Katherine ^a   Kruger, Peter ^a   Prins, John ^a   Venkatesh, Bala ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

adiponectin; inflammation; metabolic syndrome; sepsis; statins

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; SIMVASTATIN; STATIN;

ARTICLE; BODY MASS; BROWN ADIPOSE TISSUE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CRITICAL ILLNESS; DYSLIPIDEMIA; HORMONE ACTION; HUMAN; HYPERCAPNIA; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PLEIOTROPY; SEPSIS; SLEEP APNEA SYNDROME;

EID: 80052955305     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2011.04.008     Document Type: Review

References (75)

1. Y.C. Hsieh, M. Frink, and M.A. Choudhry Metabolic modulators following trauma sepsis: sex hormones Crit Care Med 35 9 Suppl Sep 2007 S621 S629
2. M.R. Losser, C. Damoisel, and D. Payen Bench-to-bedside review: glucose and stress conditions in the intensive care unit Crit Care 14 4 2010 231
3. M. Singer Mitochondrial function in sepsis: acute phase versus multiple organ failure Crit Care Med 35 9 Suppl Sep 2007 S441 S448
4. J.H. Siegel Relations between circulatory and metabolic changes in sepsis Annu Rev Med 32 1981 175 194
5. L.K. Phillips, and J.B. Prins The link between abdominal obesity and the metabolic syndrome Curr Hypertens Rep 10 2 Apr 2008 156 164
6. L. Hutley, and J.B. Prins Fat as an endocrine organ: relationship to the metabolic syndrome Am J Med Sci. 330 6 Dec 2005 280 289 (Pubitemid 41831898)
7. J.P. Whitehead, A.A. Richards, and I.J. Hickman Adiponectin-a key adipokine in the metabolic syndrome Diabetes Obes Metab 8 3 May 2006 264 280
8. S. Devaraj, D. Siegel, and I. Jialal Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep 13 1 Feb 2011 31 42
9. I. Jialal, and S. Devaraj Statin therapy for the metabolic syndrome: the evidence base Metab Syndr Relat Disord 7 5 Oct 2009 393 396
10. P. Kruger, K. Fitzsimmons, and D. Cook Statin therapy is associated with fewer deaths in patients with bacteraemia Intensive Care Med 32 1 Jan 2006 75 79 (Pubitemid 43039379)
11. P.S. Kruger Statins: the next anti-endotoxin Crit Care Resusc 8 3 Sep 2006 223 226
12. J. Vague, P. Vague, and M. Tramoni Obesity and diabetes Acta Diabetol Lat 17 2 Apr-Jun 1980 87 99
13. T.S. Ferguson, M.K. Tulloch-Reid, and N.O. Younger Prevalence of the metabolic syndrome and its components in relation to socioeconomic status among Jamaican young adults: a cross-sectional study BMC Public Health 10 2010 307
14. A.J. Cameron, D.J. Magliano, and P.Z. Zimmet The metabolic syndrome in Australia: prevalence using four definitions Diabetes Res Clin Pract 77 3 Sep 2007 471 478 (Pubitemid 47211344)
15. R. Monteiro, and I. Azevedo Chronic inflammation in obesity and the metabolic syndrome Mediators Inflamm 2010 2010
16. F.R. Jornayvaz, V.T. Samuel, and G.I. Shulman The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome Annu Rev Nutr 30 Aug 21 2010 273 290
17. A.M. Wassink, J.K. Olijhoek, and F.L. Visseren The metabolic syndrome: metabolic changes with vascular consequences Eur J Clin Invest 37 1 Jan 2007 8 17 (Pubitemid 44934767)
18. F.I. Achike, N.H. To, and H. Wang Obesity, metabolic syndrome, adipocytes and vascular function: a holistic viewpoint Clin Exp Pharmacol Physiol 38 1 Jan 2011 1 10
19. L.A. Adams, and A.E. Feldstein Nonalcoholic steatohepatitis: risk factors and diagnosis Expert Rev Gastroenterol Hepatol 4 5 Oct 2010 623 635
20. E. Maury, and S.M. Brichard Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Mol Cell Endocrinol 314 1 Jan 15 2010 1 16
21. S.R. Coughlin, L. Mawdsley, and J.A. Mugarza Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome Eur Heart J 25 9 May 2004 735 741 (Pubitemid 38647933)
22. D.J. Foster, P. Ravikumar, and D.J. Bellotto Fatty diabetic lung: altered alveolar structure and surfactant protein expression Am J Physiol Lung Cell Mol Physiol 298 3 Mar 2010 L392 L403
23. W. Ageno, C. Becattini, and T. Brighton Cardiovascular risk factors and venous thromboembolism: a meta-analysis Circulation 117 1 Jan 1 2008 93 102 (Pubitemid 350301144)
24. W. Dunn, R. Xu, and D.L. Wingard Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study Am J Gastroenterol 103 9 Sep 2008 2263 2271
25. V. Bhagat, A.L. Mindikoglu, and C.G. Nudo Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease Liver Transpl 15 12 Dec 2009 1814 1820
26. S.J. Van Cromphaut, I. Vanhorebeek, and G. Van den Berghe Glucose metabolism and insulin resistance in sepsis Curr Pharm Des 14 19 2008 1887 1899
27. B.M. Arafah Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods J Clin Endocrinol Metab 91 10 Oct 2006 3725 3745 (Pubitemid 44536835)
28. P.S. Kruger, M.L. Harward, and M.A. Jones Continuation of statin therapy in patients with presumed infection: a randomised controlled trial Am J Respir Crit Care Med Oct 19 2010
29. B. Venkatesh, I. Hickman, and J. Nisbet Changes in serum adiponectin concentrations in critical illness: a preliminary investigation Crit Care 13 4 2009 R105
30. B. Venkatesh, J. Cohen, and I. Hickman Evidence of altered cortisol metabolism in critically ill patients: a prospective study Intensive Care Med 33 10 Oct 2007 1746 1753 (Pubitemid 47476642)
31. J.R. Seckl, N.M. Morton, and K.E. Chapman Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue Recent Prog Horm Res. 59 2004 359 393
32. M.S. Cooper, I. Bujalska, and E. Rabbitt Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation J Bone Miner Res. 16 6 Jun 2001 1037 1044 (Pubitemid 32467147)
33. M.S. Cooper, and P.M. Stewart Corticosteroid insufficiency in acutely ill patients N Engl J Med 348 8 Feb 20 2003 727 734 (Pubitemid 36237043)
34. N.N. Mehta, F.C. McGillicuddy, and P.D. Anderson Experimental endotoxemia induces adipose inflammation and insulin resistance in humans Diabetes 59 1 Jan 2010 172 181
35. T. Grau, and A. Bonet Caloric intake and liver dysfunction in critically ill patients Curr Opin Clin Nutr Metab Care 12 2 Mar 2009 175 179
36. J. Ascaso, P. Gonzalez Santos, and A. Hernandez Mijares Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-forum Am J Cardiovasc Drugs 7 1 2007 39 58 (Pubitemid 46698514)
37. P.E. Marik Dyslipidemia in the critically ill Crit Care Clin 22 1 Jan 2006 151 159 viii (Pubitemid 43037115)
38. P.S. Kruger Forget glucose: what about lipids in critical illness? Crit Care Resusc 11 4 Dec 2009 305 309
39. J.I. Gallin, D. Kaye, and W.M. O'Leary Serum lipids in infection N Engl J Med 281 20 Nov 13 1969 1081 1086
40. H.W. Harris, J.E. Gosnell, and Z.L. Kumwenda The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity J Endotoxin Res. 6 6 2000 421 430 (Pubitemid 32409428)
41. H.J. van Leeuwen, E.C. Heezius, and G.M. Dallinga Lipoprotein metabolism in patients with severe sepsis Crit Care Med 31 5 May 2003 1359 1366 (Pubitemid 36583844)
42. G.F. Watts, P.H. Barrett, and D.C. Chan HDL metabolism in context: looking on the bright side Curr Opin Lipidol 19 4 Aug 2008 395 404
43. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1 Apr 2 1999 79 83 (Pubitemid 29299050)
44. J. Hung, B.M. McQuillan, and P.L. Thompson Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity Int J Obes 32 5 2008 772 779 (Pubitemid 351670618)
45. E. Hu, P. Liang, and B.M. Spiegelman AdipoQ is a novel adipose-specific gene dysregulated in obesity J Biol Chem 271 18 May 3 1996 10697 10703 (Pubitemid 26145805)
46. N. Maeda, I. Shimomura, and K. Kishida Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat Med 8 7 Jul 2002 731 737 (Pubitemid 34778727)
47. A.A. Richards, T. Stephens, and H.K. Charlton Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications Mol Endocrinol 20 7 Jul 2006 1673 1687 (Pubitemid 43967574)
48. H. Nakatani, H. Hirose, and Y. Yamamoto Significance of leptin and high-molecular weight adiponectin in the general population of Japanese male adolescents Metabolism 57 2 Feb 2008 157 162
49. K. Hara, M. Horikoshi, and T. Yamauchi Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 6 Jun 2006 1357 1362 (Pubitemid 44125935)
50. R. Basu, U.B. Pajvani, and R.A. Rizza Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects Diabetes 56 8 Aug 2007 2174 2177 (Pubitemid 47195840)
51. K. Robinson, J. Prins, and B. Venkatesh Clinical review: Adiponectin biology and its role in inflammation and critical illness Crit Care 15 2 Apr 2011 221
52. R. Ouedraogo, Y. Gong, and B. Berzins Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo J Clin Invest 117 6 Jun 2007 1718 1726 (Pubitemid 46871356)
53. H. Tsuchihashi, H. Yamamoto, and K. Maeda Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis J Surg Res 134 2 Aug 2006 348 353 (Pubitemid 44092804)
54. A. Hillenbrand, U. Knippschild, and M. Weiss Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients BMC Surg 10 2010 26
55. M. Jernas, B. Olsson, and K. Sjoholm Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness Metabolism 58 1 Jan 2009 102 108
56. L. Langouche, S. Vander Perre, and J. Frystyk Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin Crit Care 13 4 2009 R112
57. N. Ouchi, M. Ohishi, and S. Kihara Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 3 Sep 2003 231 234 (Pubitemid 37093465)
58. C. Palmer, T. Hampartzoumian, and A. Lloyd A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection Hepatology 48 2 Aug 2008 374 384
59. P. Keller, K. Moller, and K.S. Krabbe Circulating adiponectin levels during human endotoxaemia Clin Exp Immunol 134 1 Oct 2003 107 110 (Pubitemid 37186595)
60. J.M. Kaplan, A. Denenberg, and M. Monaco Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock Intensive Care Med 36 1 Jan 2009 123 130
61. A.J. Walkey, T.W. Rice, and J. Konter Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure Crit Care Med 38 12 Dec 2010 2329 2334
62. S. Shetty, C.M. Kusminski, and P.E. Scherer Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies Trends in Pharmacological Sciences 30 5 2009 234 239
63. J.M. Lehmann, L.B. Moore, and T.A. Smith-Oliver An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor gamma (PPAR gamma) J Biol Chem 270 22 Jun 2 1995 12953 12956
64. D. Auboeuf, J. Rieusset, and L. Fajas Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients Diabetes 46 8 Aug 1997 1319 1327 (Pubitemid 27315281)
65. A. Tsuchida, T. Yamauchi, and S. Takekawa Peroxisome Proliferator⠀"Activated receptor (PPAR)α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue Diabetes 54 12 December 2005 3358 3370 (Pubitemid 43334324)
66. L.R. Kurukulasuriya, and J.R. Sowers Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors Cardiovasc Diabetol 9 2010 45
67. Robinson K, Kruger P, Phillips L, Prins J, Venkatesh B. Effect of statin therapy on plasma adiponectin concentrations in patients with the sepsis syndrome: a preliminary investigation. Intensive Care Med 2011 May 27. [Epub ahead of print]
68. T. Khan, M.P. Hamilton, and D.I. Mundy Impact of simvastatin on adipose tissue: pleiotropic effects in vivo Endocrinology 150 12 Dec 2009 5262 5272
69. N. Halberg, T.D. Schraw, and Z.V. Wang Systemic fate of the adipocyte-derived factor adiponectin Diabetes 58 9 September 2009 1961 1970
70. C. Smaldone, S. Brugaletta, and V. Pazzano Immunomodulator activity of 3-hydroxy-3-methilglutaryl-CoA inhibitors Cardiovasc Hematol Agents Med Chem. 7 4 Oct 2009 279 294
71. A. Simon, E. Drewe, and J.W. van der Meer Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome Clin Pharmacol Ther 75 5 May 2004 476 483 (Pubitemid 38534568)
72. H. Nawawi, N.S. Osman, and K. Yusoff Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia Horm Metab Res. 35 8 Aug 2003 479 485 (Pubitemid 37204564)
73. S. Janda, A. Young, and J.M. Fitzgerald The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis J Crit Care 25 4 Dec 2010 656 e657 622
74. M.E. Falagas, G.C. Makris, and D.K. Matthaiou Statins for infection and sepsis: a systematic review of the clinical evidence J Antimicrob Chemother 61 4 Apr 2008 774 785 (Pubitemid 351426059)
75. A.P. Arruda, M. Milanski, and L.A. Velloso Hypothalamic inflammation and thermogenesis: the brown adipose tissue connection J Bioenerg Biomembr 43 1 Feb 2011 53 58